Skip to content

Jikei-Vildagliptin and sitagliptin with CGM TO Real blood glucose control In type 2 diAbetes

Jikei-Vildagliptin and sitagliptin with CGM TO Real blood glucose control In type 2 diAbetes - J-VICTORIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007687
Enrollment
30
Registered
2012-04-08
Start date
2012-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Sponsors

Jikei University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)HbA1c 6.5%-9.0% was not achieved after treatment by life style intervention or anti diabetes drugs for at least 1 month. 2) Given informed consent

Exclusion criteria

Exclusion criteria: 1) type 1 diabetes 2) had ketosis or coma within 6 month 3) after severe infection, operation or injury 4) past history of operation or ileus 5) has colon disorder 6) has Roemheld's syndrome, hernia or stenosis of colon 7) is pregnancy or chance of pregnant 8) impaired renal function(CCR>50ml/min, Serum Cr>1.5mg/dL for male, >1.3mg/dL for female) 9) severe liver damage 10) Under insulin treatment 11) Under treatment by other anti-diabetic drugs (if these drugs were stopped one month prior, the subject can participate this study) 12) Has allergy to DPP-4 inhibitor 13) Patient who was considered to be appropriate to this study by attending physician.

Design outcomes

Primary

MeasureTime frame
glucose variablity

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026